Dynapenia could predict chemotherapy-induced dose-limiting neurotoxicity in digestive cancer patients.
Fiche publication
Date publication
octobre 2018
Journal
BMC cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BOUCHE Olivier
Tous les auteurs :
Botsen D, Ordan MA, Barbe C, Mazza C, Perrier M, Moreau J, Brasseur M, Renard Y, Taillière B, Slimano F, Bertin E, Bouché O
Lien Pubmed
Résumé
FIGHTDIGO study showed the feasibility and acceptability of handgrip strength (HGS) measure in routine in 201 consecutive patients with digestive cancer treated with ambulatory chemotherapy. The present study focuses on the second aim of FIGHTDIGO study: the relationships between pre-therapeutic dynapenia and chemotherapy-induced Dose-Limiting Toxicities (DLT).
Mots clés
Antineoplastic agents, Digestive system neoplasms, Dose-limiting toxicity, Dynapenia, Muscle strength, Sarcopenia
Référence
BMC Cancer. 2018 Oct 4;18(1):955